These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 7263763)
1. Studies in an animal model on the effectiveness of adjuvant chemotherapy with 5-FU and BCNU in cases of colorectal adenocarcinoma. Schmitz R; Hüper J; Pichlmayr R J Cancer Res Clin Oncol; 1981; 100(2):213-20. PubMed ID: 7263763 [TBL] [Abstract][Full Text] [Related]
2. Chemotherapy of human colorectal tumor xenografts in athymic mice with clinically active drugs: 5-fluorouracil and 1-3-bis-(-2-chloroethyl)-1-nitrosourea (BCNU). Comparison with doxorubicin derivatives: 4'deoxydoxorubicin and 4'-O-methyldoxorubicin. Giuliani FC; Zirvi KA; Kaplan NO; Goldin A Int J Cancer; 1981 Jan; 27(1):5-13. PubMed ID: 7251230 [TBL] [Abstract][Full Text] [Related]
3. [Adjuvant chemotherapy of human colorectal adenocarcinoma after growth on mice with congenital thymic dysplasia ("nude"). 1. Experiments to test the feasibility of combined chemotherapy with VCR and 5-FU (author's transl)]. Schmitz R; Schmitz CA; Echtermeyer V; Pichlmayr R J Cancer Res Clin Oncol; 1980; 96(3):269-79. PubMed ID: 7430242 [TBL] [Abstract][Full Text] [Related]
4. Levamisole plus 5-fluorouracil inhibits the growth of human colorectal xenografts in nude mice. Van Ginckel R; Distelmans W; De Brabander M; Callens M; Janssens B; Jagers E; Wouters L; De Coster R; Janssen PA Eur J Cancer; 1992; 28A(6-7):1137-9. PubMed ID: 1627384 [TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy of human colorectal adenocarcinoma after growth on mice with congenital thymic dysplasia ("nude"). 2. Tumor remission following treatment with 5-FU and VCR of xenotransplanted primary human colorectal adenocarcinomas. Schmitz R; Schmitz CA; Hüper J; Richlmayr R J Cancer Res Clin Oncol; 1980; 97(1):15-21. PubMed ID: 7400203 [TBL] [Abstract][Full Text] [Related]
6. [Animal experiments using adjuvant 5-FU and BCNU chemotherapy in stomach cancer]. Knorr V; Schmitz R Chirurg; 1980 Sep; 51(9):601-5. PubMed ID: 7460686 [TBL] [Abstract][Full Text] [Related]
7. The assessment of response of murine transplantable colon tumors to combination chemotherapy. Cowen DM; Siegerstetter J; Janik AC; Double JA J Cancer Res Clin Oncol; 1982; 103(2):119-26. PubMed ID: 7096434 [TBL] [Abstract][Full Text] [Related]
8. Effects of steroid hormone therapy on primarily xenotransplanted human colorectal adenocarcinomas. Izbicki JR; Schmitz R; Hoppen HO; Izbicki W; Troidl H J Cancer Res Clin Oncol; 1984; 108(3):345-50. PubMed ID: 6511808 [TBL] [Abstract][Full Text] [Related]
9. Chemotherapy in colorectal cancer. Büyükünal E; Berkarda N; Serdengeçti S; Derman U; Berkarda B Chemioterapia; 1986 Oct; 5(5):337-40. PubMed ID: 3791482 [TBL] [Abstract][Full Text] [Related]
10. Potentiation of the antitumor action of 5-fluorouracil with 5-ethyl-2'-deoxyuridine in human colorectal tumor xenografts. Kopper L; Magyarosy E; Jeney A; Lapis K; Szabolcs A; Otvös L Oncology; 1984; 41(3):155-8. PubMed ID: 6328393 [TBL] [Abstract][Full Text] [Related]
11. Phase II evaluation of BCNU and 5-FU in gastrointestinal carcinomas. Tormey DC; Gailani S; Leone L Oncology; 1974; 29(3):244-8. PubMed ID: 4415043 [No Abstract] [Full Text] [Related]
12. Combinations of 5-FU, hypoxanthine and allopurinol in chemotherapy for human colon adenocarcinoma xenografts. Houghton JA; Houghton PJ Cancer Treat Rep; 1982 May; 66(5):1201-6. PubMed ID: 7083222 [TBL] [Abstract][Full Text] [Related]
13. Treatment of autochthonous rat colonic adenocarcinomas with a thioether-lysophospholipid derivative in mono- and combination chemotherapy. Heim ME; Swoboda M; Pahlke W; Edler L; Bicker U J Cancer Res Clin Oncol; 1984; 108(3):316-20. PubMed ID: 6549010 [TBL] [Abstract][Full Text] [Related]
14. Adriamycin, mitomycin C, and 5-fluorouracil in combination for advanced colorectal adenocarcinoma previously treated with 5-fluorouracil. Kessinger MA; Foley JF; Lemon HM Cancer Clin Trials; 1979; 2(4):317-9. PubMed ID: 394867 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical evaluation of thymidylate synthase (TS) and p16INK4a in advanced colorectal cancer: implication of TS expression in 5-FU-based adjuvant chemotherapy. Kamoshida S; Matsuoka H; Ishikawa T; Maeda K; Shimomura R; Inada K; Tsutsumi Y Jpn J Clin Oncol; 2004 Oct; 34(10):594-601. PubMed ID: 15591457 [TBL] [Abstract][Full Text] [Related]
16. Treatment with 5-FU, VCR and BCNU in tumor bearing nude mice. Köhler L; Schmitz R; Mennigen R; Fuchshuber P; Eypasch E Strahlenther Onkol; 1989 Jul; 165(7):542-4. PubMed ID: 2749493 [No Abstract] [Full Text] [Related]
18. A phase II study of the combination, 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and N-(phosphonacetyl)-L-aspartate (PALA), in patients with advanced large bowel cancer. Rubin J; Schutt AJ; O'Connell MJ; Gertz MA; Moertel CG Am J Clin Oncol; 1984 Oct; 7(5):523-5. PubMed ID: 6507373 [TBL] [Abstract][Full Text] [Related]
19. Chemotherapeutic activity and histopathologic feature of BCNU + 5-FU effect on Lewis lung carcinoma. Greco C; Calabresi F; Corsi A; Pericoli N; Caputo M Neoplasma; 1980; 27(3):279-87. PubMed ID: 7453848 [TBL] [Abstract][Full Text] [Related]